Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
   
Friday 10 July 2009
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters
Nature 284, 553 - 555 (10 April 1980); doi:10.1038/284553a0

A new immunodeficiency disorder in humans involving NK cells

John C. Roder, Tina Haliotis*, Margareta Klein*, Stefan Korec, James R. Jett, John Ortaldo, Ronald B. Heberman, Paul Katz & Anthony S. Fauci

*Department of Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada K7L 3N6 and Department of Zoology, University College, London WC1E 6JJ UK
Laboratory of Immunodiagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Laboratory of Clinical Investigation, National Institutes of Health, Bethesda, Maryland
§To whom correspondence should be addressed.

Immunodeficiency disorders have provided much information on the development and interaction of the various B and T lymphoid components in the immune system of man. As the lymphoid system becomes increasingly divided into functional subsets of cells it will be important to find immunodeficiencies affecting newly discovered cell types. Natural killer (NK) cells are a recently described but ill-defined subpopulation of lymphocytes which is thought to play an important part in surveillance against tumour development1. Mice homozygous for the beige gene were found to have a selective deficiency in NK function2 and were more susceptible to transplantation of syngeneic tumours as predicted3,26. We report here that patients carrying the analogous, autosomal recessive Chediak-Higashi (CH) gene have a profound defect in their ability to spontaneously lyse various tumour cells in vitro by either antibody-dependent or independent mechanisms. Since other cell-mediated cytolytic functions were relatively normal, these results suggest that the beige or Chediak-Higashi gene in both man and mouse controls NK function.

------------------

References
1. Kiessling, R. & Wigzell, H. Immun. Rev. 44, 165 (1979). | PubMed | ISI | ChemPort |
2. Roder, J. C. & Duwe, A. K. Nature 278, 451 (1979). | PubMed | ISI | ChemPort |
3. Karre, K., Kiessling, R., Klein, G. & Roder, J. Nature (in the press).
4. Windhorst, D. B. & Padgett, G. J. invest. Derm. 60, 529 (1973). | Article | PubMed | ISI | ChemPort |
5. Page, A. R., Berendes, H., Warner, J. & Good, R. A. Blood 20, 330 (1962). | PubMed | ISI | ChemPort |
6. Vassalli, J. D., Cranelli-Piperno, A., Griscelli, C. & Reich, E. J. exp. Med. 147, 1285 (1978). | Article | PubMed | ISI | ChemPort |
7. Dent, P. B., Fish, L. A., White, J. F. & Good, R. A. Lab. Invest. 15, 1634 (1966). | PubMed | ISI | ChemPort |
8. Gallin, J. I. et al. Blood 53, 226 (1969).
9. Root, R. K., Rosenthal, A. S. & Balestra, D. J. J. clin. Invest. 51, 649 (1972). | PubMed | ISI | ChemPort |
10. Blume, R. S. & Wolff, S. M. Medicine 51, 247 (1972). | PubMed | ISI | ChemPort |
11. Jondal, M. & Pross, H. Int. J. Cancer 15, 596 (1975). | PubMed | ISI | ChemPort |
12. Roder, J. C., Kiessling, R., Biberfeld, P. & Andersson, B. J. Immun. 121, 2509 (1978). | PubMed | ISI | ChemPort |
13. Roder, J. C., Ahrlund-Richter, L. & Jondal, M. J. exp. Med. 150, 471 (1979). | Article | PubMed | ISI | ChemPort |
14. Cudkowicz, G. & Hochman, P. S. Immun. Rev. 44, 13 (1979). | PubMed | ISI | ChemPort |
15. Roder, J. C. & Klein, M. J. Immun. 123, 2785 (1979). | PubMed | ISI | ChemPort |
16. Oliver, J. & Zurier, R. B. J. clin. Invest. 57, 1239 (1976). | PubMed | ISI | ChemPort |
17. Boxer, L. A. et al. N. Engl. J. Med. 295, 1041 (1976). | PubMed | ISI | ChemPort |
18. Tovey, M. G., Rochette-Egly, C. & Castagna, M. Proc. natn. Acad. Sci. U.S.A. 76, 3890 (1979). | ChemPort |
19. Pross, H., Gupta, S., Good, R. A. & Baines, M. G. Cell Immun. 43, 160 (1979). | ISI | ChemPort |
20. Koren, H., Amos, B. & Buckley, R. J. Immun. 120, 796 (1978). | PubMed | ISI | ChemPort |
21. Herberman, R. B. et al. Immun. Rev. 44, 43 (1979). | PubMed | ISI | ChemPort |
22. Ackerman, S. K. & Douglas, S. D. J. Immun. 120, 1372 (1978). | PubMed | ISI | ChemPort |
23. Korec, S., Herberman, R. B., Dean, J. H. & Cannon, G. B. Int. J. Cancer (in the press).
24. Ortaldo, J. R., Bonnard, G. B., Kind, P. & Herberman, R. B. J. Immun. 122, 1489 (1979). | PubMed | ISI | ChemPort |
25. Alexander, E. & Henkart, P. J. exp. Med. 143, 329 (1976). | Article | PubMed | ISI | ChemPort |
26. Talmadge, J. E., Meyers, K. M., Prieur, D. & Starkey, J. R. Nature (in the press).



© 1980 Nature Publishing Group
Privacy Policy